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COMMENTARY
Stakeholder involvement in Multi-Criteria 
Decision Analysis
Praveen Thokala1* and Guruprasad Madhavan2
From Priority Setting in Global Health Symposium Boston, MA, USA. 5–6 October 2016
Abstract 
This brief perspective highlights the importance of decision maker buy-in and ownership through stakeholder 
engagement in the co-construction of the multi-criteria decision analysis (MCDA) model. A brief historical overview of 
MCDA is presented before outlining the importance of bridging the gap (and to gain trust) between the tool devel-
opers and users. The issues with the current MCDA tool development and testing efforts are highlighted, and the 
ownership and routine adoption of the MCDA process is discussed.
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he past few years have witnessed a surge of interest in 
the use of multi criteria decision analysis (MCDA) for 
priority setting. Many diferent tools and techniques are 
available under the general heading of MCDA, and exam-
ples include the use of ‘Program budgeting and marginal 
analysis’ (PBMA) tools [1–3] for resource allocation deci-
sions by local health care budget holders; use of discrete 
choice experiments to inform priority setting [4, 5]; use 
of the Evidem framework in making decisions about 
value for money of new health care technologies [6, 7]. 
However, the use of formal MCDA tools for health care 
priority setting is still limited, with most of the published 
MCDA studies being either pilots or hypothetical in 
nature [8]. his section outlines our relections on why 
MCDA is not more widely used for priority setting and 
highlights key requirements for successful application of 
MCDA tools.
‘Buy-in’ from the key decision makers is imperative for 
the implementation of a structured priority setting pro-
cess. In other words, if there is no buy-in from the deci-
sion makers, the results of the MCDA studies will not be 
implemented. Unfortunately, many of the MCDA studies 
seen in the literature on health care priority setting seem 
to ignore this fundamental requirement, with the MCDA 
researchers and practitioners working independently 
from the key stakeholders when conducting the MCDA. 
Examples of these include determining the criteria, per-
forming the scoring and weighting independently from 
the stakeholders/decision makers. Whilst these stud-
ies may be methodologically sound, the outputs of the 
MCDA are not implemented as they are not trusted by 
the decision makers, given they had little or no involve-
ment in the MCDA process.
here may be several potential reasons for the lack 
of ‘buy-in’ from the decision makers. One could be the 
reluctance to move away from cost-efectiveness analysis 
and its legacy, even if it does not include many other fac-
tors that afect real decisions [9]. his issue is not speciic 
to MCDA; health care ield has always been slow to adopt 
new techniques/methodologies [10, 11]. MCDA might 
be seen as too objective, transparent and explicit to allow 
the lexibility for making exceptions to individual cases. 
here may also be resistance to follow a process like 
MCDA as the decision makers may not want to reveal 
a set of priorities, over concerns that they may be chal-
lenged if the priorities shift over time. Furthermore, there 
could be other cultural/political factors that may afect 
the ‘buy-in’ from the decision makers.
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he emphasis of MCDA researchers should be on edu-
cating the decision makers about the MCDA process and 
its beneits for supporting priority setting—for example, 
by conducting training courses or developing manuals to 
support MCDA process for priority setting. It should be 
noted that MCDA can help support the implementation 
of ‘accountability for reasonableness’ framework [12], put 
forward by Norman Daniels and other ethicists, which 
argues for the inclusion of due and fair process in setting 
and agreeing priorities.
‘Ownership’ of the MCDA process and results can help 
with achieving the ‘buy-in’ from the key decision makers/
stakeholders. his involves engaging the stakeholders/
decision makers in each step of the MCDA process [13], 
i.e. deining the decision problem, selecting the criteria, 
developing performance matrix, scoring alternatives and 
weighting criteria, aggregation, uncertainty analysis, and 
interpretation of results. he researchers should validate 
each step to ensure that MCDA design, input, and out-
puts are plausible and consistent with the decision maker 
objectives and stakeholder preferences [14]. Wherever 
needed, the researchers should help interpret the mean-
ing of the diferent components of MCDA to ensure con-
irmation from the stakeholders.
he aim of this ‘co-production’ between the decision 
makers and MCDA researchers is to ensure that the 
stakeholders/decision makers feel that the decision is 
‘their’ decision, not the tool’s decision. MCDA is a mech-
anism for making explicit the criteria and judgements 
that feed into the complex process of resource allocation. 
If the decision makers do not understand or feel like they 
were not of the process, they would be reluctant to use 
the MCDA results.
Many diferent tools and techniques are available under 
the general heading of MCDA. he technical complex-
ity of MCDA, especially the weighted sum model, is very 
simple (each alternative’s scores on the criteria are multi-
plied by the weights and these weighted scores are then 
summed across the criteria to get a “total value” for each 
alternative) but the challenges are in the MCDA process 
(i.e. choosing the criteria, explaining the scoring/weight-
ing to stakeholders, eliciting the preferences, presenting 
and interpreting the MCDA results). A key consideration 
is to ensure that the MCDA tools can support a commit-
tee or group of decision makers for use in real policy set-
tings, as opposed to tools designed for single users [15, 
16]. However, the MCDA tools cannot solve the problem 
on their own; they need engagement from the decision 
makers. hus, rather than developing more tools, capac-
ity building is more beneicial for the use of MCDA to 
support priority setting.
In summary, given MCDA is about eliciting the deci-
sion makers/stakeholders’ preferences, it is a fundamental 
limitation if they are not part of the whole MCDA pro-
cess. he success of MCDA for priority setting relies on 
the buy-in and engagement from the health care bodies; 
and we should focus our eforts in supporting this rather 
than developing more MCDA tools.
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